Puramed Bioscience Inc. Convertible Debt, Fair Value Disclosures
Puramed Bioscience Inc. had Convertible Debt, Fair Value Disclosures of $2.35 million as of 2014-06-30, per its 10-K filed 2014-10-14.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:ConvertibleDebtFairValueDisclosures · last filed 2014-10-14
- 2014-06-30: Convertible Debt, Fair Value Disclosures $2.35M.
- 2013-12-31: Convertible Debt, Fair Value Disclosures $882.34K.
- 2013-06-30: Convertible Debt, Fair Value Disclosures $400.27K.
| Period end | Convertible Debt, Fair Value Disclosures |
|---|---|
| 2014-06-30 | $2.35M 10-K · filed 2014-10-14 |
| 2013-12-31 | $882.34K 10-Q · filed 2014-02-19 |
| 2013-06-30 | $400.27K 10-K · filed 2014-10-14 |